Join to View Full Profile
601 Elmwood AveRochester, NY 14642
Phone+1 585-275-2542
Fax+1 585-273-1255
Dr. Thornton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterResidency, Neurology, 1989 - 1991
Oregon Health & Science University (OHSU Health)Residency, Neurology, 1982 - 1985
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 1981 - 1982
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1981
Certifications & Licensure
OR State Medical License 1983 - Present
NY State Medical License 1989 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
- Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 Start of enrollment: 2011 Jun 01
- Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Start of enrollment: 2019 Jan 01
Publications & Presentations
PubMed
- Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.Chad Rydel Heatwole, Elizabeth Luebbe, Johanna Hamel, Phillip C Mongiovi, Emma Ciafaloni
Neurology. Genetics. 2025-10-01 - Elimination of myotonia improves myopathy in a muscleblind knockout model of myotonic dystrophy.Matthew T Sipple, Sakura A Hamazaki, Vanessa Todorow, Lily A Cisco, Katherine M Lupia
Biorxiv. 2025-09-21 - 4 citationsFORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models.Timothy Weeden, Tyler Picariello, Brendan Quinn, Sean Spring, Pei-Yi Shen
Communications Medicine. 2025-01-18
Press Mentions
Celebrating Decades of Advances in Myotonic Dystrophy ResearchSeptember 17th, 2024- Triplet Therapeutics Announces Participation in Natural History Study of Myotonic Dystrophy Type 1August 18th, 2020
Grant Marks Two Decades of NIH Support for Muscular Dystrophy ResearchFebruary 25th, 2019- Join now to see all
Grant Support
- Pharmacodynamic Biomarker of Myotonic DystrophyUNIVERSITY OF ROCHESTER2023–2028
- Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1 (Renewal)VIRGINIA COMMONWEALTH UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
